Therapeutic Efficacy of a Novel βIII/βIV-tubulin Inhibitor (VERU-111) in Pancreatic Cancer
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-1009-7
Full Text
Open PDFAbstract
Available in full text
Date
January 23, 2019
Authors
Publisher
Springer Science and Business Media LLC